Researchers from The Pirbright Institute have been awarded US $5.5 million by the Bill & Melinda Gates Foundation to establish a Livestock Antibody Hub aimed at improving animal and human health globally. The ambitious programme of work will see extensive collaboration between multiple UK research organisations in order to utilise research outcomes in livestock disease and immunology to support human health as part of the ‘One Health’ agenda.
Six leading scientists from Pirbright will be involved in the project, including Professor John Hammond, Professor Venugopal Nair, Dr Simon Graham, Dr Elma Tchilian, Professor Munir Iqbal and Dr Erica Bickerton. Their combined expert knowledge will drive the study of cattle, pig and poultry antibody responses at high resolution to expand our understanding of protective immunity in species that can also be used as models for a range of human infectious diseases.
The aim is to use Pirbright’s expertise in livestock viral diseases, cutting-edge technology and unique high-containment facilities to bring antibody discovery, manipulation and testing up to the benchmark already seen in the immunological field for rodents and humans. This highly collaborative work will address the needs of the livestock research community whilst bridging the requirements of the vaccine industry.
A number of work programmes will focus on studying B cells and antibodies at multiple scales including gene expression, single cell function and the entire antibody response. Findings from this research will be used to drive vaccine selection and design and test antibody therapies with Pirbright ultimately acting as a ‘Hub’ able to provide specific methods, access to animal models and the associated expertise to drive antibody research within the ‘One Health’ agenda.
Research lead Professor John Hammond said, “New technology has given us the opportunity to utilise these detailed antibody responses to make the next generation of vaccines and therapies, which will improve animal health and ultimately human health, as well as ensuring the security of our food supply.”
Dr Doug Brown, Chief Executive of the British Society for Immunology, commented, “The UK is a world leader in veterinary immunology research, and this transformative investment from the Bill & Melinda Gates Foundation will drive the next chapter of innovation in developing new treatments and prevention options against livestock diseases. This is the single biggest investment in the immunology of livestock in the UK from an international funder, and the British Society for Immunology will do all we can to support this collaborative initiative and help maximise its impact for the benefit of human and animal health.”
For more information please contact email@example.com Tel: +44 (0) 1483 231120.
Follow The Pirbright Institute on social media: Facebook Twitter
About The Pirbright Institute
The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. Based in the UK and receiving strategic funding from the Biotechnology and Biological Sciences Research Council part of UK Research and Innovation (BBSRC UKRI), the Institute works to enhance capability to contain, control and eliminate these economically and medically important diseases through highly innovative fundamental and applied bioscience.
With an annual income in excess of £35 million from grants and commercial activity, and a total of £12.6 million strategic investment from BBSRC during 2018-2019, the Institute contributes to global food security and health, improving quality of life for animals and people.
For more information about The Pirbright Institute see: www.pirbright.ac.uk